As sociedades científicas respiratórias europeia e americana (ERS e ATS) constituíram um grupo de trabalho sobre a “Avaliação dos resultados nos ensaios clínicos na DPOC: da função pulmonar aos marcadores biológicos” para informar a comunidade de investigadores em DPOC sobre o possível uso e limitações dos resultados obtidos e marcadores usados actualmente na avaliação do impacto da terapêutica farmacológica. Com base na revisão da literatura, este documento aborda diferentes secções que avaliam marcadores e resultados específicos: função pulmonar; resultados centrados no doente; exacerbações; nortalidade; impacto social e económico; exames de imagem; marcadores não pulmonares; mínima diferença clinicamente significativa; marcadores biológicos.
Journal Information
Vol. 14. Issue 4.
Pages 579-583 (July - August 2008)
Vol. 14. Issue 4.
Pages 579-583 (July - August 2008)
Full text access
Avaliação dos resultados nos ensaios clínicos na DPOC: Da função pulmonar aos marcadores biológicos
Visits
923
M. Cazzola, W. MacNee, F.J. Martinez, K.F. Rabe
On behalf of the ATS/ERS TASK Force on outcomes of COPD. Eur Respir J 2008; 31:416-468
This item has received
Article information
Resumo
Full text is only aviable in PDF
Bibliografia
[1.]
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report (Updated 2007). www.goldcopd.org. Último acessoem 21-05-2008.
[2.]
Bergner M. The sickness impact profile. In Walker SR, ed., Quality of Life: Assessment and Application. Boston, MTP, 1987: 79–94.
[3.]
G.H. Guyatt, L.B. Berman, M. Townsend, S.O. Pugsley, L.W. Chambers.
A measure of quality of life for clinical trials in chronic lung disease.
Thorax, 42 (1987), pp. 773-778
[4.]
P.W. Jones, F.H. Quirk, C.M. Baveystock, P. Littlejohns.
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis, 145 (1992), pp. 1321-1327
[5.]
R. Garrod, J.C. Bestall, E.A. Paul, J.A. Wedzicha, P.W. Jones.
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL).
Respir Med, 94 (2000), pp. 589-596
[6.]
J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, J.A. Wedzicha.
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 581-586
[7.]
D.A. Mahler, D.H. Weinberg, C.K. Wells, A.R. Feinstein.
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.
Chest, 85 (1984), pp. 751-758
[8.]
G.A. Borg.
Psychophysical bases of perceived exertion.
Med Sci Sports Exerc, 14 (1982), pp. 377-381
[9.]
C.G. Cote, B.R. Celli.
Pulmonary rehabilitation and the BODE index in COPD.
Eur Respir J, 26 (2005), pp. 630-636
[10.]
A.M. Schols, J. Slangen, L. Volovics, E.F. Wouters.
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797
Copyright © 2008. Sociedade Portuguesa de Pneumologia